title: Clinical translation of stem cells: insight for cartilage therapies.
abstract: The limited regenerative capacity of articular cartilage and deficiencies of current treatments have motivated the investigation of new repair technologies. In vitro cartilage generation using primary cell sources is limited by cell availability and expansion potential. Pluripotent stem cells possess the capacity for chondrocytic differentiation and extended expansion, providing a potential future solution to cell-based cartilage regeneration. However, despite successes in producing cartilage using adult and embryonic stem cells, the translation of these technologies to the clinic has been severely limited. This review discusses recent advances in stem cell-based cartilage tissue engineering and the major current limitations to clinical translation of these products. Concerns regarding appropriate animal models and studies, stem cell manufacturing, and relevant regulatory processes and guidelines will be addressed. Understanding the significant hurdles limiting the clinical use of stem cell-based cartilage may guide future developments in the fields of tissue engineering and regenerative medicine.
authors.affiliation: Department of Biomedical Engineering, University of California , Davis, CA , USA .
authors.forename: Jennifer K
authors.initials: JK
authors.lastname: Lee
authors.forename: Donald J
authors.initials: DJ
authors.lastname: Responte
authors.forename: Derek D
authors.initials: DD
authors.lastname: Cissell
authors.forename: Jerry C
authors.initials: JC
authors.lastname: Hu
authors.forename: Jan A
authors.initials: JA
authors.lastname: Nolta
authors.forename: Kyriacos A
authors.initials: KA
authors.lastname: Athanasiou
mesh_terms: D000818:Animals; D002356:Cartilage; D006801:Humans; D051379:Mice; D044968:Regenerative Medicine; D013234:Stem Cells; D023822:Tissue Engineering